These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8756902)

  • 1. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
    Soyer P
    Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
    Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
    AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
    Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
    MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring enhancement on T1-weighted GRE images after ferucarbotran administration for hepatic metastasis: comparison with pathological findings: case report.
    Kitajima K; Kuwata Y; Hayashi M; Imanaka K; Kaji Y; Sugimura K
    Radiat Med; 2005 Feb; 23(1):75-9. PubMed ID: 15786756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
    Pleger B; Beyer HK; Laufer U
    Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
    Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
    Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging liver metastases: review and update.
    Kanematsu M; Kondo H; Goshima S; Kato H; Tsuge U; Hirose Y; Kim MJ; Moriyama N
    Eur J Radiol; 2006 May; 58(2):217-28. PubMed ID: 16406434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.
    Kondo H; Kanematsu M; Hoshi H; Murakami T; Kim T; Hori M; Matsuo M; Nakamura H
    AJR Am J Roentgenol; 2000 Apr; 174(4):947-54. PubMed ID: 10749228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
    Tanimoto A; Kuribayashi S
    Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.
    Oudkerk M; van den Heuvel AG; Wielopolski PA; Schmitz PI; Borel Rinkes IH; Wiggers T
    Radiology; 1997 May; 203(2):449-56. PubMed ID: 9114103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of liver tumors].
    Rummeny EJ; Reimer P; Daldrup H; Peters PE
    Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
    Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
    J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of portal perfusion abnormalities: comparison of 3 ferucarbotran-enhanced magnetic resonance imaging sequences.
    Iwazawa J; Nishida N; Yamamoto A; Nango M; Ninoi T; Murakami Y; Nakamura K; Inoue Y
    J Comput Assist Tomogr; 2006; 30(2):165-72. PubMed ID: 16628027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases.
    Del Frate C; Zuiani C; Londero V; Como G; Bazzocchi M; Mortele K; Ros PR
    AJR Am J Roentgenol; 2003 May; 180(5):1339-46. PubMed ID: 12704048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.